A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 47,351 shares of AURA stock, worth $388,278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,351
Previous 59,055 19.82%
Holding current value
$388,278
Previous $446,000 5.61%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$6.9 - $10.36 $80,757 - $121,253
-11,704 Reduced 19.82%
47,351 $421,000
Q2 2024

Aug 09, 2024

SELL
$6.81 - $7.89 $86,017 - $99,658
-12,631 Reduced 17.62%
59,055 $446,000
Q1 2024

May 09, 2024

BUY
$7.09 - $9.24 $416,636 - $542,979
58,764 Added 454.76%
71,686 $562,000
Q4 2023

Feb 09, 2024

BUY
$7.02 - $11.98 $90,712 - $154,805
12,922 New
12,922 $114,000

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $240M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.